Cosmo Pharmaceuticals N.V. (FRA:C43)
65.00
-1.50 (-2.26%)
Last updated: Jul 30, 2025
Cosmo Pharmaceuticals Employees
Cosmo Pharmaceuticals had 322 employees as of December 31, 2024. The number of employees decreased by 3 or -0.98% compared to the previous year.
Employees
322
Change (1Y)
-3
Growth (1Y)
-0.98%
Revenue / Employee
€549,009
Profits / Employee
€180,696
Market Cap
1.00B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 322 | -3 | -0.98% |
Dec 31, 2023 | 325 | 30 | 10.17% |
Dec 31, 2022 | 295 | 5 | 1.72% |
Dec 31, 2021 | 290 | 25 | 9.43% |
Dec 31, 2020 | 265 | 31 | 13.25% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Siemens Energy AG | 98,000 |
Rheinmetall AG | 28,539 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Deutsche Bank Aktiengesellschaft | 89,753 |